National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2016 (No 3) (PB 102 of 2016) (Cth)

PB 102 of 2016

National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2016 (No. 3)

National Health Act 1953

I, JULIANNE QUAINE, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated         9 December 2016

JULIANNE QUAINE

Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

1       Name of Instrument

(1)This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2016 (No 3).

(2)This Instrument may also be cited as PB 102 of 2016.

2Commencement

This Instrument commences on 1 December 2016.

3       Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010

Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010).

.

Schedule 1     Amendments

[1]           Schedule 1, entry for Sorbital + Citrate + Lauryl Sulfoacetate Sodium – Enemas 3.125g-450mg-45mg in 5ml, 12

omit from the columns headed ‘Brand, Responsible Person and Maximum Amount’ – Microlax, (JT) and 4

[2]           Schedule 2,

omit:

JT Johnson & Johnson Pacific Pty Limited 73 001 121 446